Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Dilip Davda has given "May Apply" recommendation to Valiant Laboratories IPO. Capital Market recommend to "Avoid" the IPO.
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 1 | 0 | 1 | 0 |
| % | 0.00 | 50.00 | 0.00 | 50.00 | 0.00 |
| Reviewer | Recommendation | Past Reviews |
|---|---|---|
Capital Market |
Avoid |  |
| Dilip Davda | May Apply | |
The Captial Market (CapitalMarket.com) rating for Valiant Laboratories IPO is 37. Their analysis recommends Do not subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 37 | Do not subscribe |
[Dilip Davda] The company is in the business of manufacturing APIs and bulk drugs with a prime focus on widely used paracetamol. However, the company has posted declining trends for its PAT and RoCE margins for the reported periods. Based on FY23 earnings, the issue appears fully priced. Investors may park funds for medium to long-term rewards. Read detail review...
Valiant Laboratories Limited peer comparison with similar listed entities. (Standalone) (As on March 31, 2023)
| Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | |
|---|---|---|---|---|---|
| EPS Basic | EPS Diluted | ||||
| Valiant Laboratories Limited | 8.91 | 8.91 | 30.80 | 28.86 | |
| Granules India Ltd | 21.05 | 21.00 | 115.52 | 15.06 | 18.22 |
| Jagsonpal Pharmaceuticals Limited | 10.20 | 10.20 | 6.06 | 41.54 | 16.82 |
| Alkyl Amines Chemicals Ltd | 44.75 | 44.68 | 228.41 | 55.59 | 19.56 |
| Laxmi Organic Industries Limited | 4.70 | 4.67 | 52.89 | 66.07 | 8.83 |
Notes:
Valiant Laboratories IPO Reviews, analysis and views by popular members. Read Valiant Laboratories Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 3 | 0 | 3 | 1 |
| % | 42.86 | 0.00 | 42.86 | 14.29 |
| Member | Review |
|---|---|
B.M.SURANA  IPO Guru (2600 Posts, 4800+ Likes) |
Apply for Long Term at Upper Price Band Reasonable PE
|
| UMESH Goyal |
Apply for Listing Gain at Upper Price Band can apply for listing gain September 30, 2023 2:12:29 PM |
| Keshav rocks |
Apply for Short Term at Cut-off Price Fundamentals looking good, Currently Pharma company performa well, this stock also join the party.so some listing gane and if you hold some time it will give 40-70% gain. September 29, 2023 5:27:27 PM |
Crow  IPO Mentor (700+ Posts, 900+ Likes) |
Neutral Difficult to review this because it's a single-product API company asking for money to start a subsidiary. September 29, 2023 12:04:12 PM |
| Sanny soni |
Avoid This company depending on Paracetamol based production as well as Paracetamol banned on few countries. Only in india, this kind of medicines produces and sells highly in demand. If Paracetamol will banned in future. It reflected this company directly as well as shares goes down. September 28, 2023 5:45:25 PM |
| Kumat |
Neutral Why this ipo closing dated 03/10/2023 three working days would be 27/09/2023 to 29/09/2023 ? September 28, 2023 9:46:38 AM |
| Hiren K. |
Neutral Didn't understand, why IPO date duration so long from 27th to 3rd OCT. members any comments September 27, 2023 8:45:57 AM |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
